South Korea Scraps Inheritance Tax Cuts Amid Political Stalemate
Desk
korocamia@naver.com | 2024-12-11 12:21:09
Seoul, South Korea – South Korea’s parliament has blocked a government proposal to reduce inheritance and gift taxes, dealing a blow to the administration’s efforts to stimulate the economy. The decision comes amid a broader political stalemate and growing concerns over wealth inequality.
The rejected bill would have lowered the top inheritance and gift tax rate from 50% to 40% and increased the tax-free gift amount for children. However, opposition lawmakers argued that the proposed tax cuts would primarily benefit the wealthy.
While the inheritance tax cuts were rejected, the parliament did approve the repeal of the planned financial investment income tax, which was set to be imposed on income from stocks, bonds, and other financial assets. The government had delayed the implementation of this tax due to concerns about its impact on the stock market. Additionally, the taxation of cryptocurrencies has been postponed until 2027.
The government had argued that reducing inheritance taxes would boost economic activity and encourage investment. However, critics contended that such tax cuts would primarily benefit large conglomerates and wealthy individuals.
The failure to pass the inheritance tax cuts is the latest setback for the government's economic policies. Other proposed tax cuts and incentives for businesses have also been rejected or delayed due to political opposition.
WEEKLY HOT
- 1"Steak Without Meat?" EU Bans Meat Terminology for Plant-Based Foods
- 2Historian Warns of 'Dictatorial Shift': Trump May Use Emergency Powers to Postpone November Elections
- 3Danawa Hosts 1,000 KRW Raffle for 1TB SSD Worth Over 300,000 KRW
- 4Apple's Next Leap: Will the 'MacBook Ultra' with OLED and Touch Support Redefine the Premium Laptop Market?
- 5KEXIM Ignites 'K-Finance' with 450 Billion Won Support for Taihan Cable’s Submarine Plant
- 6Japan Approves World's First iPSC-Derived Therapies: A New Era for Regenerative Medicine